Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample
Jeffrey M. Rogers, Kirsten E. Smith, Justin C. Strickland, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25

Showing 25 citing articles:

Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report
Tyler Torrico, Kajal R. Patel, Nicole Nikolov, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 9
Kratom use as more than a “self-treatment”
Kirsten E. Smith, Kelly E. Dunn, Jeffrey M. Rogers, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 6, pp. 684-694
Closed Access | Times Cited: 37
Examining the paradoxical effects of kratom: a narrative inquiry
Kirsten E. Smith, Jeffrey D. Feldman, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys
Jeffrey M. Rogers, Kayla Colvin, David H. Epstein, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use
Katherine Hill, Jeffrey M. Rogers, Oliver Grundmann, et al.
The American Journal of Drug and Alcohol Abuse (2025), pp. 1-13
Open Access
Kratom drinks and consumption trends: insights from Reddit
Teresa Perry, Sayorn Chin
Journal of Substance Use (2025), pp. 1-9
Closed Access
Health Effects Associated With Kratom (Mitragyna speciosa) and Polysubstance Use: A Narrative Review
Catherine W. Striley, Carolin C. Hoeflich, Andrew T Viegas, et al.
Substance Abuse Research and Treatment (2022) Vol. 16
Open Access | Times Cited: 16
Kratom’s Emergence and Persistence Within the US Polydrug Epidemic
Kirsten E. Smith, Jeffrey M. Rogers, Jeffrey D. Feldman
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 262-271
Open Access | Times Cited: 10
Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature
Cornel N. Stanciu, Saeed Ahmed, Samantha A. Gnanasegaram, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 5, pp. 509-528
Closed Access | Times Cited: 14
Kratom use categories and their associations with co-occurring substance use and mental health disorder symptoms during the COVID-19 pandemic
David Adzrago, Elizabeth O. Obekpa, Tiffany Suragh, et al.
Drug and Alcohol Dependence (2022) Vol. 239, pp. 109605-109605
Closed Access | Times Cited: 11
Kratom availability in California vape shops
Molly A. Bowdring, Eric C. Leas, Monika Vishwakarma, et al.
Preventive Medicine Reports (2023) Vol. 35, pp. 102380-102380
Open Access | Times Cited: 5
Beneficial and Adverse Health Effects of Kratom (Mitragyna speciosa): A Critical Review of the Literature
J. Thomas Heywood, S. Smallets, Dennis J. Paustenbach
Food and Chemical Toxicology (2024) Vol. 192, pp. 114913-114913
Closed Access | Times Cited: 1
Dynamic Topic Modeling of Kratom Use and Experiences: Insights on 13 years of Reddit Discussions
Seraphina Fong, Alessandro Carollo, Elisabeth Prevete, et al.
(2024)
Open Access | Times Cited: 1
Associations Between Opioid and Kratom Use in the USA: Differences by Race/Ethnicity and Sexual Orientation
Cassidy R. LoParco, Carlton Bone, Carla J. Berg, et al.
Journal of Racial and Ethnic Health Disparities (2024)
Closed Access | Times Cited: 1
The association between E-cigarette use and Kratom use among US adults
Juhan Lee, Javier Ponce Terashima, Maria A. Parker
Preventive Medicine (2022) Vol. 164, pp. 107295-107295
Closed Access | Times Cited: 7
Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder – a narrative review
Alexandra Arenson, Cynthia I. Campbell, Ilan Remler
Journal of Addictive Diseases (2023) Vol. 42, Iss. 3, pp. 253-263
Closed Access | Times Cited: 3
A case of fatal overdose involving both hydromorphone and kratom
Thomas Shi, Jennifer Shea
Journal of Forensic Sciences (2023) Vol. 69, Iss. 1, pp. 355-358
Open Access | Times Cited: 3
Prevalence, Characteristics, and Reasons for Kratom Use among Psychiatrically Ill Inpatients Who Use Substances
Cornel N. Stanciu, Saeed Ahmed, Zouina Sarfraz, et al.
Journal of Dual Diagnosis (2023) Vol. 20, Iss. 2, pp. 87-97
Closed Access | Times Cited: 2
Characterization of kratom use and knowledge at a rural, Oregon community health center
Kerri Raven Cauldron, Natalea Braden‐Suchy, Adriane N. Irwin
Journal of the American Pharmacists Association (2024) Vol. 64, Iss. 5, pp. 102138-102138
Closed Access
Kratom (<i>Mitragyna speciosa</i>) Use and Mental Health: A Systematic Review and Multilevel Meta-Analysis
Yuting Yang, Christian P. Müller, Darshan Singh
European Addiction Research (2024) Vol. 30, Iss. 4, pp. 252-274
Closed Access
Important factors associated with using kratom among the U. S. population aged 12 years and above in 2019
Suraj Dhankikar, Akansha Arewar, Megan Quinn, et al.
International Journal of Basic & Clinical Pharmacology (2024) Vol. 13, Iss. 5, pp. 605-611
Open Access
Kratom: A Narrative Review of the Possible Clinical Uses and Dangers of This Opioid-Like Plant
Amber N. Edinoff, Sarah E. Kaufman, Taylor C Mahoney, et al.
Cureus (2024)
Open Access
The Associations of Kratom (Mitragynine), Opioids, Other Substances, and Sociodemographic Variables to Drug Intoxication–related Mortality
Armiel Suriaga, Ruth M. Tappen, Christopher R. McCurdy, et al.
Journal of Addiction Medicine (2024)
Closed Access
Kratom (Mitragyna speciosa): eine psychoaktive Pflanze mit Chancen und Risiken
Maximilian Gahr
Fortschritte der Neurologie · Psychiatrie (2022) Vol. 91, Iss. 11, pp. 455-465
Closed Access | Times Cited: 1
Kratom (Mitragyna speciosa)
Kirsten E. Smith, Oliver Grundmann, Marc T. Swogger, et al.
Oxford University Press eBooks (2023), pp. 386-418
Closed Access
Page 1

Scroll to top